Synopsis
Synopsis
0
USDMF
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Apo Domperidone
2. Apo-domperidone
3. Domidon
4. Domperidon
5. Domperidon Al
6. Domperidon Hexal
7. Domperidon Stada
8. Domperidon Teva
9. Domperidon-teva
10. Domperidona Gamir
11. Domperidone
12. Domperidone Maleate (1:1)
13. Domperidone Monohydrochloride
14. Gamir, Domperidona
15. Gastrocure
16. Hexal, Domperidon
17. Maleate, Domperidone
18. Monohydrochloride, Domperidone
19. Motilium
20. Nauzelin
21. Novo Domperidone
22. Novo-domperidone
23. Nu Domperidone
24. Nu-domperidone
25. Pridys
26. Pms Domperidone
27. Pms-domperidone
28. R-33,812
29. R-33812
30. R33,812
31. R33812
32. Ratio Domperidone
33. Ratio-domperidone
34. Stada, Domperidon
1. 83898-65-1
2. 99497-03-7
3. 899u5wf46a
4. 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)propyl]piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one Maleate
5. (z)-but-2-enedioic Acid;6-chloro-3-[1-[3-(2-oxo-3h-benzimidazol-1-yl)propyl]piperidin-4-yl]-1h-benzimidazol-2-one
6. Prestwick-06g02
7. Chebi:59812
8. 2h-benzimidazol-2-one,5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-, (2z)-2-butenedioate
9. 5-chloro-1-(1-(3-(2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)propyl)piperidin-4-yl)-1,3-dihydro-2h-benzimidazol-2-one Maleate
10. Unii-899u5wf46a
11. Domperidone (tn)
12. Einecs 281-277-7
13. Schembl447643
14. Chembl3436365
15. Domperidone (as Maleate)
16. Hy-b0411a
17. Dtxsid901019221
18. Domperidone Maleate [mart.]
19. Zda49703
20. Domperidone Maleate [who-dd]
21. Mfcd07370074
22. Akos025312518
23. Ncgc00017157-01
24. 5-chloro-1-(1-(3-(2-oxo-2,3-dihydro-1h-benzo[d]imidazol-1-yl)propyl)piperidin-4-yl)-1h-benzo[d]imidazol-2(3h)-one Maleate
25. Domperidone Maleate [ep Monograph]
26. Cs-0013583
27. D07868
28. 497d037
29. Q27126907
30. 5-chloro-1-(1-(3-(2-oxobenzimidazolin-1-yl)propyl)-4-piperidyl)benzimidazolin-2-one Maleate
| Molecular Weight | 542.0 g/mol |
|---|---|
| Molecular Formula | C26H28ClN5O6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 541.1728113 g/mol |
| Monoisotopic Mass | 541.1728113 g/mol |
| Topological Polar Surface Area | 143 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 774 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Domperidone Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Domperidone Maleate, including repackagers and relabelers. The FDA regulates Domperidone Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Domperidone Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Domperidone Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Domperidone Maleate supplier is an individual or a company that provides Domperidone Maleate active pharmaceutical ingredient (API) or Domperidone Maleate finished formulations upon request. The Domperidone Maleate suppliers may include Domperidone Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Domperidone Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Domperidone Maleate Drug Master File in Korea (Domperidone Maleate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Domperidone Maleate. The MFDS reviews the Domperidone Maleate KDMF as part of the drug registration process and uses the information provided in the Domperidone Maleate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Domperidone Maleate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Domperidone Maleate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Domperidone Maleate suppliers with KDMF on PharmaCompass.
A Domperidone Maleate CEP of the European Pharmacopoeia monograph is often referred to as a Domperidone Maleate Certificate of Suitability (COS). The purpose of a Domperidone Maleate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Domperidone Maleate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Domperidone Maleate to their clients by showing that a Domperidone Maleate CEP has been issued for it. The manufacturer submits a Domperidone Maleate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Domperidone Maleate CEP holder for the record. Additionally, the data presented in the Domperidone Maleate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Domperidone Maleate DMF.
A Domperidone Maleate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Domperidone Maleate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Domperidone Maleate suppliers with CEP (COS) on PharmaCompass.
A Domperidone Maleate written confirmation (Domperidone Maleate WC) is an official document issued by a regulatory agency to a Domperidone Maleate manufacturer, verifying that the manufacturing facility of a Domperidone Maleate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Domperidone Maleate APIs or Domperidone Maleate finished pharmaceutical products to another nation, regulatory agencies frequently require a Domperidone Maleate WC (written confirmation) as part of the regulatory process.
click here to find a list of Domperidone Maleate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Domperidone Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Domperidone Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Domperidone Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Domperidone Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Domperidone Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Domperidone Maleate suppliers with NDC on PharmaCompass.
Domperidone Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Domperidone Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Domperidone Maleate GMP manufacturer or Domperidone Maleate GMP API supplier for your needs.
A Domperidone Maleate CoA (Certificate of Analysis) is a formal document that attests to Domperidone Maleate's compliance with Domperidone Maleate specifications and serves as a tool for batch-level quality control.
Domperidone Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Domperidone Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Domperidone Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Domperidone Maleate EP), Domperidone Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Domperidone Maleate USP).
LOOKING FOR A SUPPLIER?
